Use of cetrorelix to induce an enhanced or decreased immune response without lowering sex hormones to levels below castration level

摘要

Described is the use of appropriate doses of cetrorelix (an LHRH-antagonist) to lower sex hormone levels resulting in an enhancement or a decrease in the T-cell population in an individual suffering from a disease that will respond favourably to such modification. The preferred dosage range is from 5 mg to 120 mg over a period of 1 to 8 weeks.